by Neumentum Pharmaceuticals | Jan 6, 2020 | In The Media, Press Releases
PALO ALTO, Calif., January 6, 2020 – Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2020 Biotech Showcase being held...
by Neumentum Pharmaceuticals | Nov 14, 2019 | In The Media, Press Releases
PALO ALTO, Calif., November 14, 2019 – Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Joseph Pergolizzi, Jr., M.D. and Robert Raffa, Ph.D., will both present keynote speeches at the...
by Neumentum Pharmaceuticals | Oct 17, 2019 | In The Media, Press Releases
PALO ALTO, Calif., October 17, 2019 – Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2019 BIO Investor Forum being held October...
by Sky Striar | Oct 10, 2019 | In The Media, Press Releases
Agreement significantly expands Neumentum’s pipeline of investigational pain therapies aimed at addressing the growing need for innovative analgesics PALO ALTO, Calif., October 10, 2019 – Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain...
by Sky Striar | Sep 5, 2019 | Press Releases
Neumentum’s poster presentations #39, #40, #41 and #42 from PAINWeek are now available to view. – Results Support What Has the Potential To Be the First-Ever Non-Steroidal Anti-Inflammatory (NSAID) Approved for Continuous Infusion – Results Confirm...
by admin | May 15, 2019 | In The Media, Press Releases
PALO ALTO, Calif., May 15, 2019 – Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2019 BIO International Convention being held...
